137 related articles for article (PubMed ID: 8831228)
21. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
[TBL] [Abstract][Full Text] [Related]
22. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera.
Sandler MP; Bax JJ; Patton JA; Visser FC; Martin WH; Wijns W
J Nucl Med; 1998 Dec; 39(12):2035-43. PubMed ID: 9867138
[TBL] [Abstract][Full Text] [Related]
23. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
[TBL] [Abstract][Full Text] [Related]
24. Rest distribution of 99mTc-MIBI in patients with coronary artery disease assessed by SPECT: comparison with the distribution of [18F]FDG assessed by PET.
Gang H; Lucignani G; Landoni C; Galli L; Vanoli G; Rossetti C; Paganelli G; Fazio F
J Nucl Biol Med (1991); 1994 Dec; 38(4):540-4. PubMed ID: 7786915
[TBL] [Abstract][Full Text] [Related]
25. [Performance of a multispect 2 gamma camera for imaging 511-keV gamma rays].
Schaefer A; Oberhausen E
Nuklearmedizin; 1995 Feb; 34(1):40-6. PubMed ID: 7724363
[TBL] [Abstract][Full Text] [Related]
26. SPECT imaging of fluorine-18.
Leichner PK; Morgan HT; Holdeman KP; Harrison KA; Valentino F; Lexa R; Kelly RF; Hawkins WG; Dalrymple GV
J Nucl Med; 1995 Aug; 36(8):1472-5. PubMed ID: 7629597
[TBL] [Abstract][Full Text] [Related]
27. [123I-alpha-methyltyrosine scintigraphy in malignant melanoma].
Steinert H; Böni R; Huch-Böni RA; Capaul R; von Schulthess GK; Westera G
Nuklearmedizin; 1997 Mar; 36(2):36-41. PubMed ID: 9148271
[TBL] [Abstract][Full Text] [Related]
28. The role of hybrid cameras in oncology.
Delbeke D; Sandler MP
Semin Nucl Med; 2000 Oct; 30(4):268-80. PubMed ID: 11105928
[TBL] [Abstract][Full Text] [Related]
29. Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer.
Lonneux M; Delval D; Bausart R; Moens R; Willockx R; Van Mael P; Declerck P; Jamar F; Zreik H; Pauwels S
Nucl Med Commun; 1998 Nov; 19(11):1047-54. PubMed ID: 9861621
[TBL] [Abstract][Full Text] [Related]
30. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
Shreve PD; Steventon RS; Deters EC; Kison PV; Gross MD; Wahl RL
Radiology; 1998 May; 207(2):431-7. PubMed ID: 9577492
[TBL] [Abstract][Full Text] [Related]
31. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
[TBL] [Abstract][Full Text] [Related]
32. Scintigraphy with [18F]2-fluoro-2-deoxy-D-glucose of cancer patients.
Paul R; Roeda D; Johansson R; Ahonen A; Haaparanta M; Solin O; Sipilä H
Int J Rad Appl Instrum B; 1986; 13(1):7-12. PubMed ID: 3771240
[TBL] [Abstract][Full Text] [Related]
33. Optimized technical considerations for acquiring high-quality FDG studies with a dual-headed gamma camera.
Sajdak R; Ariola-Pienschke E
J Nucl Med Technol; 1998 Dec; 26(4):245-7. PubMed ID: 9884935
[TBL] [Abstract][Full Text] [Related]
34. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders.
Delbeke D; Patton JA; Martin WH; Sandler MP
J Nucl Med; 1999 Jan; 40(1):110-7. PubMed ID: 9935066
[TBL] [Abstract][Full Text] [Related]
35. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
Garcia R; Kim EE; Wong FC; Korkmaz M; Wong WH; Yang DJ; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1476-9. PubMed ID: 8790197
[TBL] [Abstract][Full Text] [Related]
36. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
Mukherji SK; Drane WE; Mancuso AA; Parsons JT; Mendenhall WM; Stringer S
Radiology; 1996 Jun; 199(3):761-6. PubMed ID: 8638002
[TBL] [Abstract][Full Text] [Related]
37. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy.
Hoekstra OS; Ossenkoppele GJ; Golding R; van Lingen A; Visser GW; Teule GJ; Huijgens PC
J Nucl Med; 1993 Oct; 34(10):1706-10. PubMed ID: 8410287
[TBL] [Abstract][Full Text] [Related]
38. [18Fluoro-FDG SPECT for the demonstration of hibernating myocardium: an interim account].
Alexander C; Schaefer A; Trampert L; Oberhausen E; Kirsch CM; Berberich R
Nuklearmedizin; 1997 Jun; 36(4):125-30. PubMed ID: 9289698
[TBL] [Abstract][Full Text] [Related]
39. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
Neumann DR; Esselstyn CB; Kim EY
J Nucl Med; 1996 Dec; 37(12):2000-1. PubMed ID: 8970522
[TBL] [Abstract][Full Text] [Related]
40. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
Brock CS; Meikle SR; Price P
Eur J Nucl Med; 1997 Jun; 24(6):691-705. PubMed ID: 9169580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]